Chesapeake Util (CPK) Q3 2026 Earnings Call Transcript

Chesapeake Utilities reported Q3 adjusted EPS of $0.89, up 9% year over year, adjusted net income of $21.6 million, up 11%, and adjusted gross margin of $148.7 million, up 9%. Management reaffirmed 2028 adjusted EPS guidance of $7.75–$8.00 and expects 2026 capital investment of $550 million–$600 million; gas transmission margin is projected at about $33 million in 2026 and more than $50 million in 2027. Higher payroll and benefit costs reduced EPS by $0.12, and the Worcester Resiliency Upgrade estimate rose $25 million to $125 million; the company also announced a 51%-owned Florida Energy Pathway joint venture with NextEra Energy Resources.

Analysis

The key underwriting tension is not the quarter’s growth rate but the conversion of a large regulated buildout into per-share returns. CPK’s transmission and infrastructure earnings are arriving alongside higher depreciation, financing drag and planned external funding; continued equity issuance could dilute the very EPS growth investors are capitalizing. The $225 million ATM is a funding option, not evidence of an imminent issuance, but it raises the bar for incremental project returns. Watch capex completion, rate-base recovery and share-count growth together—not EPS alone.

FEP has meaningful upside optionality if South Florida demand supports added compression, but that is a 2030-era payoff, not a near-term earnings catalyst. Steel-price monitoring and permitting (management expects 12–18 months) create scope for commitment delays or cost escalation. NextEra Energy Resources’ 49% project stake may help execution, but the call provides no basis to quantify a material NEE earnings contribution. SpaceX’s separate self-build plan limits the case for treating it as a likely anchor customer; CPK says its pipeline plans do not depend on SpaceX.

Near term, the Florida City Gas final rate decision and Worcester commissioning/rate recovery matter more than broad demand optimism. Worcester’s higher capex is a project-level return and execution risk even with updated rates approved; verify the final cost, allowed recovery and operating costs. Healthcare claims may normalize, but treating them as a one-off is management’s view, not yet demonstrated. The contrarian point: headline EPS growth may understate the capital intensity and equity-supply overhang. Without valuation, rate-case terms and project-level returns, the call alone does not establish an attractive entry.

Key Decisions for Investors

• CPK: no earnings-call-only chase. Consider a staged long only if valuation compensates for financing/dilution risk and the Florida City Gas order supports recovery; invalidate on an adverse order, capex overruns without matching recovery, or sustained share-count growth that erodes per-share guidance.
• Over the next 1–3 months, track the Florida PSC staff recommendation and final order, Worcester commissioning and approved-rate contribution, and whether healthcare costs recur. These are more actionable catalysts than FEP’s long-dated demand upside.
• Treat FEP as a monitored option, not base-case value: watch permitting progress, steel commitments/pricing, contracted shipper capacity and any incremental commitments. Delay or material cost increases weaken the project-return thesis; additional firm demand and disciplined spend strengthen it.
• Do not attribute a material benefit to NEE from the joint venture absent disclosure of its investment economics or earnings contribution. Likewise, do not underwrite CPK to SpaceX volumes: the company says its plans do not rely on that customer, whose separate pipeline could reduce the opportunity.